Marstrand-Joergensen, Maja R.
Laurell, Gjertrud L.
Herrmann, Susan
Nasser, Arafat
Johansen, Annette
Lund, Anton
Andersen, Thomas L.
Knudsen, Gitte M.
Pinborg, Lars H.
Funding for this research was provided by:
National Hospital
Article History
Received: 30 January 2024
Accepted: 7 May 2024
First Online: 17 May 2024
Declarations
:
: The study protocol follows the Helsinki Declaration (), and was prior to initiation of the study approved by the Committees on Health Research Ethics in the Capital Region of Denmark (H-21031962) and the Danish Data Protection Agency (P-2021-664).
: All included healthy volunteers gave informed written consent prior to study initiation.
: GMK: Has, within the last 3 years, served as a speaker for Angelini, Abbvie, Compass, and H. Lundbeck and as a consultant for Sanos, Gilgamesh, Pure Technologies, Onsero, and Pangea Botanica. LHP: Has received honoraria as a speaker for Eisai and UCB. MRMJ: Received sponsorship from Jazz Pharmaceuticals for attendance at the 14th European Epilepsy Congress. All other authors declare no conflict of interest.